iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $34.83 and traded as low as $34.25. iShares Neuroscience and Healthcare ETF shares last traded at $34.79, with a volume of 2,512 shares changing hands.
iShares Neuroscience and Healthcare ETF Stock Down 0.2%
The company has a market cap of $6.96 million, a P/E ratio of 15.61 and a beta of 0.80. The business’s 50 day moving average is $33.90 and its 200 day moving average is $34.83.
iShares Neuroscience and Healthcare ETF Company Profile
The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.
Further Reading
- Five stocks we like better than iShares Neuroscience and Healthcare ETF
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for iShares Neuroscience and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Neuroscience and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.
